204 related articles for article (PubMed ID: 14764663)
1. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2.
Sheikh F; Baurin VV; Lewis-Antes A; Shah NK; Smirnov SV; Anantha S; Dickensheets H; Dumoutier L; Renauld JC; Zdanov A; Donnelly RP; Kotenko SV
J Immunol; 2004 Feb; 172(4):2006-10. PubMed ID: 14764663
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10.
Crepaldi L; Gasperini S; Lapinet JA; Calzetti F; Pinardi C; Liu Y; Zurawski S; de Waal Malefyt R; Moore KW; Cassatella MA
J Immunol; 2001 Aug; 167(4):2312-22. PubMed ID: 11490020
[TBL] [Abstract][Full Text] [Related]
3. Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation.
Ding Y; Qin L; Zamarin D; Kotenko SV; Pestka S; Moore KW; Bromberg JS
J Immunol; 2001 Dec; 167(12):6884-92. PubMed ID: 11739506
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.
Nagalakshmi ML; Rascle A; Zurawski S; Menon S; de Waal Malefyt R
Int Immunopharmacol; 2004 May; 4(5):679-91. PubMed ID: 15120652
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex.
Asao H; Okuyama C; Kumaki S; Ishii N; Tsuchiya S; Foster D; Sugamura K
J Immunol; 2001 Jul; 167(1):1-5. PubMed ID: 11418623
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types.
Dumoutier L; Leemans C; Lejeune D; Kotenko SV; Renauld JC
J Immunol; 2001 Oct; 167(7):3545-9. PubMed ID: 11564763
[TBL] [Abstract][Full Text] [Related]
7. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
Umeshita-Suyama R; Sugimoto R; Akaiwa M; Arima K; Yu B; Wada M; Kuwano M; Nakajima K; Hamasaki N; Izuhara K
Int Immunol; 2000 Nov; 12(11):1499-509. PubMed ID: 11058569
[TBL] [Abstract][Full Text] [Related]
8. The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains.
Hör S; Pirzer H; Dumoutier L; Bauer F; Wittmann S; Sticht H; Renauld JC; de Waal Malefyt R; Fickenscher H
J Biol Chem; 2004 Aug; 279(32):33343-51. PubMed ID: 15178681
[TBL] [Abstract][Full Text] [Related]
9. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells.
Jurlander J; Lai CF; Tan J; Chou CC; Geisler CH; Schriber J; Blumenson LE; Narula SK; Baumann H; Caligiuri MA
Blood; 1997 Jun; 89(11):4146-52. PubMed ID: 9166857
[TBL] [Abstract][Full Text] [Related]
10. Mast cells express novel functional IL-15 receptor alpha isoforms.
Bulanova E; Budagian V; Orinska Z; Krause H; Paus R; Bulfone-Paus S
J Immunol; 2003 May; 170(10):5045-55. PubMed ID: 12734349
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of IL-10 signaling reveals novel insights on the contribution of the intracellular domain of the IL-10R2 chain.
Wilbers RHP; van Raaij DR; Westerhof LB; Bakker J; Smant G; Schots A
PLoS One; 2017; 12(10):e0186317. PubMed ID: 29016674
[TBL] [Abstract][Full Text] [Related]
12. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.
Chada S; Mhashilkar AM; Ramesh R; Mumm JB; Sutton RB; Bocangel D; Zheng M; Grimm EA; Ekmekcioglu S
Mol Ther; 2004 Dec; 10(6):1085-95. PubMed ID: 15564140
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists.
Fernandez S; Jose P; Avdiushko MG; Kaplan AM; Cohen DA
J Immunol; 2004 Feb; 172(4):2613-20. PubMed ID: 14764735
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
15. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.
O'Farrell AM; Liu Y; Moore KW; Mui AL
EMBO J; 1998 Feb; 17(4):1006-18. PubMed ID: 9463379
[TBL] [Abstract][Full Text] [Related]
16. High affinity receptor for IgG (Fc gamma RI/CD64) gene and STAT protein binding to the IFN-gamma response region (GRR) are regulated differentially in human neutrophils and monocytes by IL-10.
Bovolenta C; Gasperini S; McDonald PP; Cassatella MA
J Immunol; 1998 Jan; 160(2):911-9. PubMed ID: 9551929
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-26, a highly cationic T-cell cytokine targeting epithelial cells.
Braum O; Pirzer H; Fickenscher H
Antiinflamm Antiallergy Agents Med Chem; 2012; 11(3):221-9. PubMed ID: 23106140
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
19. IL-23: a cytokine that acts on memory T cells.
Frucht DM
Sci STKE; 2002 Jan; 2002(114):pe1. PubMed ID: 11784889
[TBL] [Abstract][Full Text] [Related]
20. Is there an interaction between interleukin-10 and interleukin-22?
Wolk K; Witte E; Reineke U; Witte K; Friedrich M; Sterry W; Asadullah K; Volk HD; Sabat R
Genes Immun; 2005 Feb; 6(1):8-18. PubMed ID: 15526001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
